Live feed
Filing
SC 13G
SC 13G0001104659-20-016345·VANGUARD GROUP INC
Schedule 13G ownership disclosure
ZIOPHARM ONCOLOGY INC
Security class unavailable · CUSIP: 98973P101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,595,011
- Percent of class
- 6.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-016345
- Form type
- SC 13G
- Filer
- VANGUARD GROUP INC
- CIK
- CIK 102909
- Filed
- Feb 11, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership